{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:45:55Z","timestamp":1792449955595,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TP22"],"award-info":[{"award-number":["TP22"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1292\/2 TPQ1"],"award-info":[{"award-number":["SFB1292\/2 TPQ1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["318346496"],"award-info":[{"award-number":["318346496"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MC U105178805"],"award-info":[{"award-number":["MC U105178805"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012353","name":"Deutschen Konsortium f\u00fcr Translationale Krebsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC U105178805"],"award-info":[{"award-number":["MC U105178805"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC UU12022\/5"],"award-info":[{"award-number":["MC UU12022\/5"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011880","name":"Acad\u00e9mie de recherche et d'enseignement sup\u00e9rieur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.celrep.2026.117527","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:44:42Z","timestamp":1781210682000},"page":"117527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cancer-associated fibroblast subtypes differentially modulate natural killer cells in cancer"],"prefix":"10.1016","volume":"45","author":[{"given":"Leonor Nunes","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafsa","family":"Munir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibone Thate","family":"Arrazola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias M.","family":"Gaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Boulanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.F.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9757-2512","authenticated-orcid":false,"given":"Andrew N.J.","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline D.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117527_bib1","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and Activity of Anti\u2013PD-L1 Antibody in Patients with Advanced Cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.celrep.2026.117527_bib2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S1470-2045(19)30388-2","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study","volume":"20","author":"Robert","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.celrep.2026.117527_bib3","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.celrep.2026.117527_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer \u2014 clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.117527_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-00280-x","article-title":"The updated landscape of tumor microenvironment and drug repurposing","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.celrep.2026.117527_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05351-1","article-title":"Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2026.117527_bib7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41416-019-0683-3","article-title":"Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma","volume":"122","author":"De Jesus-Acosta","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2026.117527_bib8","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1200\/JCO.20.00590","article-title":"Randomized phase III trial of pegvorhyaluronidase alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma","volume":"38","author":"Van Cutsem","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.117527_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2026.117527_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107628","article-title":"Single-Cell RNA Sequencing Reveals a Dynamic Stromal Niche That Supports Tumor Growth","volume":"31","author":"Davidson","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117527_bib11","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.117527_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117527_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"Il1-induced Jak\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.117527_bib14","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ccell.2022.04.011","article-title":"Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer","volume":"40","author":"Huang","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117527_bib15","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41423-024-01161-x","article-title":"Tissue-specific features of innate lymphoid cells in antiviral defense","volume":"21","author":"Piersma","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.celrep.2026.117527_bib16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.immuni.2008.02.016","article-title":"NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy","volume":"28","author":"Guerra","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117527_bib17","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(00)03231-1","article-title":"Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: An 11-year follow-up study of a general population","volume":"356","author":"Imai","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2026.117527_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01869","article-title":"Natural killer cells: Development, maturation, and clinical utilization","volume":"9","author":"Abel","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.117527_bib19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/imm.12921","article-title":"Natural killer cell cytotoxicity and its regulation by inhibitory receptors","volume":"154","author":"Kumar","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.celrep.2026.117527_bib20","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control","volume":"172","author":"B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117527_bib21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12967-022-03437-0","article-title":"Natural killer cells: a promising immunotherapy for cancer","volume":"20","author":"Chu","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.celrep.2026.117527_bib22","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","article-title":"Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer","volume":"105","author":"Miller","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2026.117527_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41423-019-0224-2","article-title":"Targeting natural killer cells in solid tumors","volume":"16","author":"Habif","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.celrep.2026.117527_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-022-01672-z","article-title":"NK cells and solid tumors: therapeutic potential and persisting obstacles","volume":"21","author":"Tong","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.celrep.2026.117527_bib25","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s41590-024-01884-z","article-title":"Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping","volume":"25","author":"Netskar","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117527_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2024.106898","article-title":"Pancreatic ductal adenocarcinoma microenvironment: Soluble factors and cancer associated fibroblasts as modulators of NK cell functions","volume":"269","author":"Carlomagno","year":"2024","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.celrep.2026.117527_bib27","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.bbrc.2017.12.083","article-title":"NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer","volume":"495","author":"Hoshikawa","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celrep.2026.117527_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00496","article-title":"Defective localization with impaired tumor cytotoxicity contributes to the immune escape of NK cells in pancreatic cancer patients","volume":"10","author":"Lim","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.117527_bib29","article-title":"Empowering pancreatic tumor homing with augmented anti-tumor potency of CXCR2-tethered CAR-NK cells","volume":"32","author":"Yoon","year":"2024","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.celrep.2026.117527_bib30","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3892\/ijo.2016.3631","article-title":"Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR\/CD155), a ligand of activating NK receptor","volume":"49","author":"Inoue","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.celrep.2026.117527_bib31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canlet.2011.12.020","article-title":"Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO","volume":"318","author":"Li","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.celrep.2026.117527_bib32","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming Growth Factor-\u03b2 Signaling in Immunity and Cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117527_bib33","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/onc.2013.191","article-title":"Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression","volume":"33","author":"Comito","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2026.117527_bib34","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/2159-8290.CD-20-0775","article-title":"Netrin G1 promotes pancreatic tumorigenesis through cancer-associated fibroblast\u2013driven nutritional support and immunosuppression","volume":"11","author":"Francescone","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.117527_bib35","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1002\/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4","article-title":"CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells","volume":"31","author":"Jacobs","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2026.117527_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao4908","article-title":"Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases","volume":"360","author":"Pommier","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117527_bib37","first-page":"14","article-title":"Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL-KrasG12D\/+;LSL-Trp53R172H\/+;Pdx-1-Cre), Its Variants and Their Application in Immuno-oncology Drug Discovery","volume":"73","author":"Lee","year":"2016","journal-title":"Curr. Protoc. Pharmacol.\/editorial board"},{"key":"10.1016\/j.celrep.2026.117527_bib38","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1182\/blood-2008-10-187179","article-title":"Maturation of mouse NK cells is a 4-stage developmental program","volume":"113","author":"Chiossone","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2026.117527_bib39","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ni.3800","article-title":"Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells","volume":"18","author":"Gao","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117527_bib40","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1038\/s41467-020-19920-5","article-title":"TGF\u03b2-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts","volume":"11","author":"Grauel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117527_bib41","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ccell.2021.06.017","article-title":"Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity","volume":"39","author":"Hutton","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117527_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12943-024-02191-9","article-title":"Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response","volume":"24","author":"Jenkins","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.celrep.2026.117527_bib43","doi-asserted-by":"crossref","first-page":"20009","DOI":"10.1073\/pnas.1013805107","article-title":"Autocrine TGF-\u03b2 and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts","volume":"107","author":"Kojima","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117527_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202303720","article-title":"Modeling Structural Elements and Functional Responses to Lymphatic-Delivered Cues in a Murine Lymph Node on a Chip","volume":"13","author":"Mazzaglia","year":"2024","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.celrep.2026.117527_bib45","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-021-03614-z","article-title":"Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy","volume":"594","author":"Correia","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117527_bib46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cyto.2019.02.001","article-title":"The role of cytokines in the regulation of NK cells in the tumor environment","volume":"117","author":"Konjevi\u0107","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.celrep.2026.117527_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01602","article-title":"Complement receptor 3 has negative impact on tumor surveillance through suppression of natural killer cell function","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.117527_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-20982-2","article-title":"Stromal-driven and Amyloid \u03b2-dependent induction of neutrophil extracellular traps modulates tumor growth","volume":"12","author":"Munir","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117527_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102246","article-title":"Extracellular matrix\u2013natural killer cell interactome: an uncharted territory in health and disease","volume":"78","author":"Vyas","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.celrep.2026.117527_bib50","doi-asserted-by":"crossref","first-page":"20847","DOI":"10.1073\/pnas.0906481106","article-title":"Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity","volume":"106","author":"Balsamo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117527_bib51","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117527_bib52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-6980(94)90074-4","article-title":"NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G\/H synthase\/cyclooxygenase (COX-2) activity in vitro","volume":"47","author":"Futaki","year":"1994","journal-title":"Prostaglandins"},{"key":"10.1016\/j.celrep.2026.117527_bib53","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00262-011-1064-9","article-title":"Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4","volume":"60","author":"Holt","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2026.117527_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102282","article-title":"A practical distribution pattern of \u03b1-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma","volume":"52","author":"Li","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.celrep.2026.117527_bib55","doi-asserted-by":"crossref","DOI":"10.1007\/s00423-024-03355-3","article-title":"The radiomorphological appearance of the invasive margin in pancreatic cancer is associated with tumor budding","volume":"409","author":"Mayer","year":"2024","journal-title":"Langenbecks Arch. Surg."},{"key":"10.1016\/j.celrep.2026.117527_bib56","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1158\/2159-8290.CD-24-0131","article-title":"Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer","volume":"15","author":"Ben-Shmuel","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.117527_bib57","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1038\/s41467-023-40850-5","article-title":"Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors","volume":"14","author":"Xiao","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117527_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-44789-z","article-title":"Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity","volume":"15","author":"Dean","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117527_bib59","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/cmi.2016.28","article-title":"Liver-infiltrating CD11b-CD27- NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression","volume":"14","author":"Zhang","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.celrep.2026.117527_bib60","doi-asserted-by":"crossref","first-page":"8826","DOI":"10.1073\/pnas.092258599","article-title":"Recognition of a virus-encoded ligand by a natural killer cell activation receptor","volume":"99","author":"Smith","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117527_bib61","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/leu.2015.260","article-title":"CD56 dim CD57+ NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT","volume":"30","author":"Cichocki","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2026.117527_bib62","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ccell.2023.01.001","article-title":"Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117527_bib63","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/2159-8290.CD-23-0426","article-title":"Senescent CAFs mediate Immunosuppression and Drive Breast Cancer Progression","volume":"14","author":"Ye","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.117527_bib64","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117527_bib65","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117527_bib66","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1038\/s41467-021-23583-1","article-title":"Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis","volume":"12","author":"Jungwirth","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117527_bib67","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","article-title":"Single-cell RNA sequencing reveals stromal evolution into LRRC15+ myofibroblasts as a determinant of patient response to cancer immunotherapy","volume":"10","author":"Dominguez","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.117527_bib68","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1158\/2159-8290.CD-23-0428","article-title":"Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer","volume":"14","author":"Belle","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.117527_bib69","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117527_bib70","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1136\/gutjnl-2022-329371","article-title":"Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancer","volume":"72","author":"Karamitopoulou","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.celrep.2026.117527_bib71","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1158\/2159-8290.CD-20-1484","article-title":"Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL-6 mediated Therapy Resistance in Pancreatic Cancer","volume":"12","author":"McAndrews","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.117527_bib72","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1158\/1535-7163.MCT-12-0342","article-title":"Cell intrinsic role of COX-2 in pancreatic cancer development","volume":"11","author":"Hill","year":"2012","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.celrep.2026.117527_bib73","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-023-06685-2","article-title":"IL-1\u03b2+ macrophages fuel pathogenic inflammation in pancreatic cancer","volume":"623","author":"Caronni","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117527_bib75","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Hingorani","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117527_bib76","first-page":"265","article-title":"Cell detection with star-convex polygons","author":"Schmidt","year":"2018","journal-title":"Lect. Notes Comput. Sci. (including Subser. Lect. Notes Artif. Intell. Lect. Notes Bioinformatics) 11071 LNCS"},{"key":"10.1016\/j.celrep.2026.117527_bib74","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1093\/bioinformatics\/btw413","article-title":"MorphoLibJ: integrated library and plugins for mathematical morphology with ImageJ","volume":"32","author":"Legland","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2026.117527_bib77","unstructured":"Partek, an Illumina company (2024). Partek\u2122 Flow\u2122 (Version 11.0) [Computer software]."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726006054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726006054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:52:57Z","timestamp":1790311977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726006054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2211124726006054"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117527","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer-associated fibroblast subtypes differentially modulate natural killer cells in cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 MRC Laboratory of Molecular Biology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117527"}}